3 Results for "

PAT-1251

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "PAT-1251" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-107422
CAS No.: 2007885-39-2
Purity:  99.52%
Synonyms: PAT-1251; GB2064
Target:  

Monoamine Oxidase

Research Areas:  

Inflammation/Immunology

PAT-1251 is a potent, selective and oral lysyl oxidase-like 2 (LOXL2) inhibitor, with IC50s of 0.71 and 1.17 μM for hLOXL2 and hLOXL3, respectively, and also potently inhibits mouse, rat, and dog LOXL2 (IC50s, 0.10, 0.12, and 0.16 μM, respectively); PAT-1251 is used in the research of fibrotic diseases .
Cat. No.: HY-107422A
CAS No.: 2098884-53-6
Synonyms: PAT-1251 hydrochloride; GB2064 hydrochloride
Target:  

Monoamine Oxidase

Research Areas:  

Inflammation/Immunology

PAT-1251 Hydrochloride is a potent, selective and oral lysyl oxidase-like 2 (LOXL2) inhibitor, with IC50s of 0.71 and 1.17 μM for hLOXL2 and hLOXL3, respectively, and also potently inhibits mouse, rat, and dog LOXL2 (IC50s, 0.10, 0.12, and 0.16 μM, respectively). PAT-1251 Hydrochloride is used in the research of fibrotic diseases.
Cat. No.: HY-107422R
CAS No.: 2007885-39-2
Synonyms: PAT-1251 (Standard); GB2064 (Standard)
Lenumlostat (Standard) is the analytical standard of Lenumlostat (HY-107422). This product is intended for research and analytical applications. PAT-1251 is a potent, selective and oral lysyl oxidase-like 2 (LOXL2) inhibitor, with IC50s of 0.71 and 1.17 μM for hLOXL2 and hLOXL3, respectively, and also potently inhibits mouse, rat, and dog LOXL2 (IC50s, 0.10, 0.12, and 0.16 μM, respectively); PAT-1251 is used in the research of fibrotic diseases .